Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences

References

• Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13:S45–S50.
   PubMed Web of Science ®Google Scholar
• Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301–1320.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111(12):1006–1009.
   PubMed Web of Science ®Google Scholar
• Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25(12):2878–2886.
   PubMed Web of Science ®Google Scholar
• Pearle MS, Calhoun EA, Curhan GC, Urologic diseases in America project: urolithiasis. J Urol. 2005;173(3):848–857.
   PubMed Web of Science ®Google Scholar
• Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68(4):1808–1814.
   PubMed Web of Science ®Google Scholar
• Scales CD, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–165.
   PubMed Web of Science ®Google Scholar
• Chen Z, Prosperi M, Victoria BY. Prevalence of kidney stones in the USA: the National Health and Nutrition Evaluation Survey. J Clin Urol. 2019;12(4):296–302.
   Web of Science ®Google Scholar
• Wu W, Yang D, Tiselius HG, et al. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results. Urology. 2014;83(4):732–737.
   PubMed Web of Science ®Google Scholar
• Spradling K, Vernez SL, Khoyliar C, et al. Prevalence of hyperoxaluria in urinary stone formers: chronological and geographical trends and a literature review. J Endourol. 2016;30(4):469–475.
   PubMed Web of Science ®Google Scholar
• Baggio B, Gambaro G, Favaro S, et al. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease. Nephron. 1983;35(1):11–14.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Speizer FE, et al. Twenty-four–hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59(6):2290–2298.
   PubMed Web of Science ®Google Scholar
• Hatch M. Oxalate status in stone-formers. two distinct hyperoxaluric entities. Urol Res. 1993;21(1):55–59.
   PubMedGoogle Scholar
• Hess B, Hasler-Strub U, Ackermann D, et al. Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant. 1997;12(7):1362–1368.
   PubMed Web of Science ®Google Scholar
• Jaeger P, Portmann L, Bugnon JM, et al. Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis. Schweiz Med Wochenschr. 1982;112(49):1795–1798.
   PubMedGoogle Scholar
• Laminski NA, Meyers AM, Kruger M, et al. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br J Urol. 1991;68(5):454–458.
   PubMedGoogle Scholar
• Yagisawa T, Hayashi T, Yoshida A, et al. Metabolic characteristics of the elderly with recurrent calcium oxalate stones. BJU Int. 1999;9:924–928.
   Google Scholar
• Yagisawa T, Chandhoke PS, Fan J. Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol. 1999;161(5):1449–1452.
   PubMed Web of Science ®Google Scholar
• Maloney ME, Springhart WP, Ekeruo WO, et al. Ethnic background has minimal impact on the etiology of nephrolithiasis. J Urol. 2005;173(6):2001–2004.
   PubMed Web of Science ®Google Scholar
• Ahmad I, Pansota MS, Tariq M, et. al. Frequency of metabolic abnormalities in urinary stones patients. Pak J Med Sci. 2013;29(6):1363–1366.
   PubMed Web of Science ®Google Scholar
• Amaro CR, Goldberg J, Amaro JL, et al. Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol. 2005;31(1):29–33.
   PubMedGoogle Scholar
• Amaro CR, Goldberg J, Damasio PC, et al. An update on metabolic assessment in patients with urinary lithiasis. World J Urol. 2015;33(1):125–129.
   PubMed Web of Science ®Google Scholar
• Eisner BH, Sheth S, Dretler SP, et al. Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers. Urology. 2012;80(4):776–779.
   PubMed Web of Science ®Google Scholar
• Ferraro PM, Robertson WG, Johri N, et al. A London experience 1995–2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease. QJM. 2015;108(7):561–568.
   PubMed Web of Science ®Google Scholar
• Abu-Ghanem Y, Kleinmann N, Winkler HZ, et al. Nephrolithiasis in Israel: epidemiological characteristics of return for patients in a tertiary care center. Isr Med Assoc J. 2016;18(12):725–728.
   PubMed Web of Science ®Google Scholar
• Hadian B, Zafar-Mohtashami A, Ghorbani F. Study of urine composition of patients with recurrent nephrolithiasisin Lorestan, Iran. Iran J Kidney Dis. 2018;12(1):22–26.
   PubMed Web of Science ®Google Scholar
• Hussein NS, Sadiq SM, Kamaliah MD, et al. Twenty-four-hour urine constituents in stone formers: a study from the northeast part of Peninsular Malaysia. Saudi J Kidney Dis Transpl. 2013;24(3):630–637.
   PubMedGoogle Scholar
• Kang HW, Seo SP, Ha YS, et al. Chronological trends in clinical and urinary metabolic features over 20 years in Korean urolithiasis patients. J Korean Med Sci. 2017;32(9):1496–1501.
   PubMed Web of Science ®Google Scholar
• Kıraç M, Küpeli B, Irkilata L, et al. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones. Kaohsiung J Med Sci. 2013;29(2):88–92.
   PubMed Web of Science ®Google Scholar
• Kumar R, Kapoor R, Mittal B, et al. Evaluation of urinary abnormalities in urolithiasis patients: a study from North India. Indian J Clin Biochem. 2003;18(2):209–215.
   PubMedGoogle Scholar
• Mittal RD, Kumar R, Mittal B, et al. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract. 2003;12(4):208–213.
   PubMed Web of Science ®Google Scholar
• Ortiz-Alvarado O, Miyaoka R, Kriedberg C, et al. Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients. Urology. 2011;77(5):1054–1058.
   PubMed Web of Science ®Google Scholar
• Otto BJ, Bozorgmehri S, Kuo J, et al. Age, body mass index, and gender predict 24-hour urine parameters in recurrent idiopathic calcium oxalate stone formers. J Endourol. 2017;31(12):1335–1341.
   PubMed Web of Science ®Google Scholar
• Serra A, Domingos F, Salgueiro C, et al. Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal. Acta Med Port. 2004;17(1):27–34.
   PubMedGoogle Scholar
• Siener R, Schade N, Nicolay C, et al. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005;173(5):1601–1605.
   PubMed Web of Science ®Google Scholar
• Spivacow FR, del Valle EE, Negri AL, et al. Biochemical diagnosis in 3040 kidney stone formers in Argentina. Urolithiasis. 2015;43(4):323–330.
   PubMed Web of Science ®Google Scholar
• Stitchantrakul W, Kochakarn W, Ruangraksa C, et al. Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai. 2007;90(4):688–698.
   PubMedGoogle Scholar
• Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367(9507):333–344.
   PubMed Web of Science ®Google Scholar
• Xu LHR, Adams-Huet B, Poindexter JR, et al. Temporal changes in kidney stone composition and in risk factors predisposing to stone formation. J Urol. 2017;197(6):1465–1471.
   PubMed Web of Science ®Google Scholar
• Kohjimoto Y, Sasaki Y, Iguchi M, et al. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kid Disease. 2013;61(6):923–929.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Curhan CC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–462.
   PubMed Web of Science ®Google Scholar
• Rendina D, De Filippo G, D'Elia L, et al. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol. 2014;27(4):371–376.
   PubMed Web of Science ®Google Scholar
• Sakhaee K. Unraveling the mechanisms of obesity-induced hyperoxaluria. Kidney Int. 2018;93(5):1038–1040.
   PubMed Web of Science ®Google Scholar
• Milose JC, Kaufman SR, Hollenbeck BK, et al. Prevalence of 24-hour urine collection in high risk stone formers. J Urol. 2014;191(2):376–380.
   PubMed Web of Science ®Google Scholar
• Imamura F, Micha R, Khatibzadeh S, et al. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health. 2015;3(3):e132–e142.
   PubMed Web of Science ®Google Scholar
• Della Guardia L, Roggi C, Cena H. Diet-induced acidosis and alkali supplementation. Int J Food Sci Nutr. 2016;67(7):754–761.
   PubMed Web of Science ®Google Scholar
• Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA. 2008;105(28):9841–9846.
   PubMed Web of Science ®Google Scholar
• Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46(3):893–899.
   PubMed Web of Science ®Google Scholar
• Bazyar H, Ahmadi A, Zare Javid A, et al. The association between dietary intakes and stone formation in patients with urinary stones in Shiraz. Med J Islam Repub Iran. 2019;33:8.
   PubMedGoogle Scholar
• Nouvenne A, Ticinesi A, Morelli I, et al. Fad diets and their effect on urinary stone formation. Transl Androl Urol. 2014;3(3):303–312.
   PubMedGoogle Scholar
• Reddy ST1, Wang CY, Sakhaee K, et al. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis. 2002;40(2):265–274.
   PubMed Web of Science ®Google Scholar
• Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999;13(9):679–685.
   PubMed Web of Science ®Google Scholar
• Barcelo P, Wuhl O, Servitge E, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150(6):1761–1764.
   PubMed Web of Science ®Google Scholar
• Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–843.
   PubMed Web of Science ®Google Scholar